Vecuronium Bromide
Product Images NDC 63323-782

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 63323-782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10vial

10vial
A warning and dosage information panel for Vecuronium Bromide for Injection by Fresenius Kabi USA, LLC. It states the product strength as 10 mg and cautions that it is a paralyzing agent intended for intravenous use only. It also notes the concentration of 1 mg/mL when reconstituted to 10 mL.*
FDA Label Image

Tray10g

Tray10g
Vecuronium Bromide for Injection 10 mg lyophilized powder in 10 x 10 mg vials, labeled as a paralyzing agent. The label includes a warning that the drug is a paralyzing agent and specifies it is for intravenous use only. The product is manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Carton20mg

Carton20mg
Label for Vecuronium Bromide for Injection, 20 mg, lyophilized powder in vials. The label includes a warning indicating the product is a paralyzing agent and is for intravenous use only. The labeler is Fresenius Kabi USA, LLC, and the packaging contains 10 vials of 20 mg each.*
FDA Label Image
FDA Label Image

Structure (Ver Structure)

Structure (Ver Structure)
Chemical structure diagram of Vecuronium Bromide showing its molecular formula with labeled functional groups and bromide ion.*
FDA Label Image

Vial20

Vial20
Label for Vecuronium Bromide for Injection 20 mg by Fresenius Kabi USA, LLC. It specifies the drug is a paralyzing agent labeled for intravenous use only, with a concentration reference of 1 mg/mL when reconstituted to 20 mL. The label includes a warning in red about its paralytic properties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.